Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference29 articles.
1. Medical management of glaucoma;Alward;N Engl J Med,1998
2. Definition of glaucoma: clinical and experimental concepts;Casson;Clin Exp Ophthalmol,2012
3. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration;Am J Ophthalmol,2000
4. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial;Heijl;Arch Ophthalmol,2002
5. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002
Cited by 198 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. RNA-seq transcriptomic profiling of TGF-β2-exposed human trabecular meshwork explants: Advancing insights beyond conventional cell culture models;Experimental Cell Research;2024-10
2. Crystalline keratopathy following long-term netarsudil therapy;American Journal of Ophthalmology Case Reports;2024-09
3. Adjunctive use of netarsudil 0.02% in the treatment of refractory glaucoma: a one year analysis;International Ophthalmology;2024-07-24
4. Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3);American Journal of Ophthalmology;2024-07
5. Updates on Pediatric Glaucoma: Medical and Surgical Interventions;Current Ophthalmology Reports;2024-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3